MCT4-IN-2
MCT4-IN-2 is an orally active monocarboxylate transporter MCT4 inhibitor. MCT4-IN-2 inhibits the activity of MCT4. MCT4-IN-2 can be used for the research of inflammatory diseases, proliferative diseases and pulmonary fibrosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2230187-60-5
- Formule: C27H31N3O4
- Masse moléculaire:461.55
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
MCT4 |
In Vitro
MCT4-IN-2 attenuates the transformation of fibroblasts into myofibroblasts and reduces the production of the extracellular matrix protein α-smooth muscle actin (αSMA)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Pulmonary fibrosis mice[1]
-
Dosage:3 mg/kg
-
Administration:p.o.; twice daily
-
Result:Effectively reduced pulmonary fibrosis in vivo (in both young and aged mice).
There was no significant additive effect when used in combination with Pirfenidone or Nintedanib.
Chemical Information
-
CAS No. 2230187-60-5
-
Masse moléculaire 461.55
-
Formule C27H31N3O4
-
SMILES
O=C(C(C)(C)OCC1=NN(C(C2=CC(OC3CCC3)=CC=C2)=C1)C4=C(N5CCC5)C=CC=C4)O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)